About Pricing FAQs Providers Blog

Loading clinical trials...

Your health journey, clearly organized.

Find Clinical Trials →

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Female Upper Genital Tract in HIV-infected Women | Clinical Trials | Clareo Health

Back to clinical trial search

COMPLETEDNCT02160392

Female Upper Genital Tract in HIV-infected Women

The female upper genital tract is a unique compartment involved in HIV pathogenesis.

Lead sponsor: University of North Carolina, Chapel Hill•1 U.S. locations•View source on ClinicalTrials.gov

Clareo plain-language summary

What this study is about

Generating AI summary...

Save this trial guide to your notes

Keep your clinical trial research organized — questions to ask, what to expect, and key details.

Sponsors

Lead Sponsor

University of North Carolina, Chapel Hill

The persistent detection of HIV in the female genital tract in spite of ART is unexplained, and it is possible the uterine endometrium serve as a reservoir. There are limited data regarding the interaction between HIV expression, antiretroviral therapy (ART) and host immune system in the uterine endometrium.

Age

25 - 50 years

Sex

FEMALE

Healthy Volunteers

Yes

Inclusion Criteria

•Regularly menstruating women (between 21-42 days)
•between ages 25-50 years
•Fully suppressed by antiretroviral therapy with plasma HIV RNA \< 40 copies/mL within the last 6 months.

Exclusion Criteria

•Pregnant or planning pregnancy
•Unwilling to use 2 forms of contraception (condoms + hormonal) if they did not have previous bilateral tubal ligation procedure
•Intrauterine device in place
•Untreated cervical infection (N. gonnorhea, C. trachomatis)
•Taking immunosuppressive medications

Related studies

Secondary Cervical Cancer Prevention of Vulnerable Women With HPV and HIV Co-infection in India

NCT07209917 · Cervical Cancer, Human Papillomavirus (HPV) Infection, and more

An Effectiveness Trial of the PrEP for WINGS Study

NCT06853314 · HIV Infections, Alcohol Use Disorder, and more

Polypharmacy on Healthy Aging in People Living With HIV Over the Age of 75

NCT07388394 · Virus-HIV

RECRUITINGPhase 1

A Clinical Trial Investigating the Safety and Biological Activity of the Antibody BNT351 in Adults Living Without and With HIV

NCT07392372 · HIV -1 Infection

Behavioral Activation and Risk Reduction for Stimulant Use Among Sexually Active Adolescents and Young Adults

NCT06444360 · HIV

View all related studies →

Data from ClinicalTrials.govLast updated on ClinicalTrials.gov: June 10, 2014Terms

Trial snapshot

StatusCOMPLETED

Phase—

Enrollment26

Start dateMay 2010

Last updatedJun 10, 2014

Condition

Locations shown

UNC

Chapel Hill, North Carolina

For caregivers

Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.

Start free trial →

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: June 10, 2014Data synced to Clareo: July 13, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions